Radiopharm Theranostics (RADX) Invested Capital (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Invested Capital for 2 consecutive years, with $75.0 million as the latest value for Q2 2025.

• Quarterly Invested Capital rose 23.35% to $75.0 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $75.0 million through Jun 2025, up 23.35% year-over-year, with the annual reading at $75.0 million for FY2025, 23.35% up from the prior year.
• Invested Capital for Q2 2025 was $75.0 million at Radiopharm Theranostics, up from $60.8 million in the prior quarter.
• The five-year high for Invested Capital was $75.0 million in Q2 2025, with the low at $60.8 million in Q2 2024.

Peer Comparison